We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Looks Into Possible Opioid, OTC Mix-Up at Novartis Plant
FDA Looks Into Possible Opioid, OTC Mix-Up at Novartis Plant
January 13, 2012
The FDA is looking into possible commingling of OTC drugs and prescription opioids at a Novartis Consumer Health plant as it works with the company to fix manufacturing problems there.